Find Academic Supervisors

Anastasia Chrysovalantou ChatziioannouView profile

Researcher

• Metabolomics
• Analytical Chemistry
• Proteomics
• +3 more

Anastasia Chrysovalantou Chatziioannou is a Scientist specializing in metabolomics and analytical chemistry at the Nutrition and Metabolism Branch of the International Agency for Research on Cancer (IARC). Her work focuses on developing advanced analytical techniques for clinical biomarker identification, particularly in neonatal conditions like necrotizing enterocolitis and sepsis. She holds a PhD in Analytical Chemistry from Aristotle University of Thessaloniki (2019), an MSc in Chemical Analysis from National & Kapodistrian University of Athens (2014), and a BSc in Chemistry from Aristotle University (2011). Her research interests emphasize metabolic profiling optimization, proteomics applications in neonatal critical care, and biomarker validation through mass spectrometry. She contributes to international scientific communities via membership in the Metabolomics Society and the Association of Greek Chemists. Key research trends in her publications include applying GC-MS and LC-MS/MS technologies to clinical samples, optimizing sample preparation protocols, and identifying metabolomic signatures for disease diagnosis. Her work bridges analytical chemistry innovations with clinical applications in neonatal and infectious disease contexts.

• Analytical Chemistry
• Bioanalytical Chemistry
• Capillary Electrophoresis
• +5 more

Lisa Holland is a Professor in the C. Eugene Bennett Department of Chemistry at West Virginia University (WVU), affiliated with the Eberly College of Arts and Science. She holds a Ph.D. from the University of North Carolina at Chapel Hill and has been a faculty member at WVU since 2002. Her research focuses on developing miniaturized analytical separation techniques, particularly capillary electrophoresis and microfluidics, to analyze biological pharmaceuticals, glycans, nanoparticles, and disease markers. She leads the Holland Group, which collaborates with institutions like The Ohio State University and NIOSH. Education: B.S., Chemistry, University of Maryland, College Park Ph.D., Analytical Chemistry, University of North Carolina at Chapel Hill Postdoctoral Fellowship, University of Kansas (Pharmaceutical Chemistry) Research Interests: Her work emphasizes bioanalytical methods for characterizing biopharmaceuticals, glycosylation patterns, and viral enzymes. Techniques include capillary electrophoresis with nanogel matrices, mass spectrometry interfacing, and low-cost microfluidic devices for education and diagnostics. Publications & Awards: Over 50 peer-reviewed articles, with recent work on nanogel-based enzyme assays and microfluidic educational tools. Recognized with NIH R01 and NSF awards. Active in professional societies like the American Chemical Society. Grants & Leadership: Principal Investigator on projects funded by NIH, NSF, and industry. Served as Chair of the ACS Chromatography Division. Developed REU programs to engage undergraduates in nanotechnology research. Labs/Teams: Leads the Holland Group at WVU, focusing on bioanalytical chemistry and separation science. Collaborates with multidisciplinary teams in nanotechnology, virology, and environmental analysis.

Joseph RowerView profile

Academic

• Pharmacokinetics-Pharmacodynamics (PK-PD) Relationships
• Bioanalytical Methods Development
• Pediatric Clinical Pharmacology
• +7 more

Dr. Joseph Rower is a Research Assistant Professor in the Department of Pharmacology and Toxicology and Adjunct Assistant Professor in Pediatrics at the University of Utah's College of Pharmacy. He serves as Associate Director of the Center for Human Toxicology. Undergraduate: California Lutheran University, BS in Chemistry and Mathematics Doctoral: University of Colorado Anschutz Medical Campus, PhD in Pharmaceutical Sciences Postdoctoral Fellowships: Systems Biology at University of Colorado, Antiviral Pharmacology at University of Colorado, and Pediatric Clinical Pharmacology at University of Utah Dr. Rower's research focuses on pediatric pharmacology , particularly validating bioanalytical methods for small blood volumes to improve clinical care for children. His lab explores personalized dosing strategies , tacrolimus in pediatric transplantation , (val)ganciclovir for congenital cytomegalovirus , and cannabis pharmacokinetics in adolescents . Collaborative work spans preclinical models, clinical trials, and pharmacometric modeling. Recent publications emphasize pediatric pharmacokinetic-pharmacodynamic relationships , bioanalytical innovations , and personalized medicine applications in diverse areas including infectious disease , neurology , and critical care . Scientific Awards Board-certified clinical pharmacologist (Diplomate of the American Board of Clinical Pharmacology) Dr. Rower's lab within the Center for Human Toxicology integrates bioanalysis and pharmacometrics to identify patient-specific factors affecting drug pharmacokinetics. Collaborations include Dr. Albert Park (pediatric ENT), Dr. Chris Reilly's team (TRP channels and pulmonary toxicology), and international partners via the University of Utah's cores.

• Nanoplasmonics
• Nano-optics
• Biochips
• +7 more

Li Yi is a Tenured Associate Professor at the School of Microelectronics, Southern University of Science and Technology (SUSTech) , with expertise in nanoplasmonics, nano-optics, and biochips. His career spans institutions including KU Leuven, Imperial College London, and Ludwig-Maximilians-Universität München. Education: Ph.D. (2015, KU Leuven & IMEC), M.S. (2010) and B.S. (2007) in Biomedical Engineering from Zhejiang University. Career: Associate Professor (2021–present) and Assistant Professor (2019–2020) at SUSTech; LMU Research Fellow (2018–2019); Research Associate (2015–2018) at Imperial College London. Research Interests focus on single-molecule biochips, DNA data storage, and nanopore sequencing. His work bridges nanotechnology with biomedical applications, including: Integrated circuit-compatible optical/electrical devices Computational lithography and nanoscale imaging Neural network training for biosensing Publications include >60 peer-reviewed articles with 25 H-index. His recent work emphasizes DNA-based data encryption, nanopore engineering, and portable biosensing systems. Key journals: Nature Communications, Nano Letters, ACS Nano. Scientific Awards : LMU Research Fellowship (Marie Curie COFUND) imec Excellent Scientific Award Shenzhen 'Peacock Plan' Category B Talent Outstanding Poster Award at Surface Plasmon Photonics 2017 Participation in Lindau Nobel Laureates Meeting (2019) Grants include Ministry of Science and Technology Key R&D Youth Program, NSFC General Program, and Guangdong Provincial Key Program. His lab develops: Fluidic nanopores for single-molecule sensing Optical antennas for enhanced detection Training programs in biochip design and nano-optics

• Pharmacology
• Pharmacy
• Material Science
• +3 more

Magdalena Urszula Prokopowicz is a Professor and currently serves as the Dean of the Faculty of Pharmacy at the Medical University of Gdańsk. She holds a position in the Department of Physical Chemistry within the same faculty. Her research focuses on pharmacology and pharmacy, with emphasis on silica materials, drug release mechanisms, and controlled drug delivery systems. She has contributed significantly to the field through 126 publications, 2 patents, and 2 research projects. Education: Doctorate awarded in 1999, habilitation (Prof. Dr. Habil.) Her scientific achievements include work on silica polymers, sol-gel methods, and biomaterial applications in therapy. She is a member of the PRA 3 research team focused on bioanalysis and therapy using advanced engineered models. Over her career, she has supervised 2 promoted theses and holds a MEiN Score of 3,027. Her research portfolio spans drug delivery systems, nanotechnology, and material science applications in pharmaceutical contexts. She actively participates in interdisciplinary projects involving silica xerogels, hydroxyapatite, and 3D bioengineered models for therapeutic innovation.

Joshua EdelView profile

Professor

• Analytical Chemistry
• Medical Biotechnology
• Human Biophysics
• +3 more

Joshua Edel is a Professor of Biosensing & Analytical Sciences at Imperial College London's Department of Chemistry within the Faculty of Natural Sciences. He specializes in developing trace analyte analytical platforms, including bioanalytical sensors for clinical applications. His work focuses on single-molecule detection, nanopore sensors, and microfluidic systems. Edel has published over 180 research articles and secured prestigious grants like the ERC Starting Grant (2011) and ERC Consolidator Award (2017). His research spans nanobiotechnology, plasmonic sensors, and biosensor innovation. Education: PhD in developing single-molecule detection within microfluidic systems from Imperial College London (2003). Postdoctoral research at Cornell University (School of Applied and Engineering Physics) and a fellowship at Harvard University's Rowland Institute (single-molecule biophysics). Research Interests: Edel’s lab pioneers techniques such as high-throughput droplet microfluidics, optical/electrical single-molecule sensors, and plasmonic nanopore sensors. His work addresses challenges in diagnostics, nanoelectronics, and structural chemistry. Key areas include developing selective biosensors for clinical samples and advancing nanoscale probing technologies. Grants & Awards: ERC Starting Grant (2011): Rare event bioanalysis ERC Consolidator Award (2017): Selective single-molecule biosensors Funding from EPSRC, Wellcome Trust, and industrial partners Advising & Labs: Edel leads projects in Imperial’s Department of Chemistry and collaborates across disciplines. His lab develops cutting-edge tools like nanoscale tweezers for single-cell analysis and nanofluidic platforms for biomarker detection. He actively consults in biosensing technology.

• Cancer Biology
• Pharmacology
• Cell Cycle Regulation
• +3 more

Su Su Thae Hnit is a Research and Teaching Fellow in Bioanalysis at the School of Natural Sciences, Macquarie University, within the Faculty of Science and Engineering. She holds a Bachelor of Medical Science (Honours) from Western Sydney University (2013) and a PhD in Biological Science (2018). Her research focuses on identifying plant-derived chemical components to impede cancer cell proliferation, with a particular emphasis on developing innovative technologies like Surface Enhanced Raman Scattering (SERS) for rapid protein target detection and proteomics tools via the Australian Proteome Analysis Facility (APAF). She collaborates with Prof. Yuling Wang’s team and Prof. Qihan Dong’s Cancer Biology Group at the University of Sydney. Education: BMedSci (Hons) 2013, PhD in Biological Science 2018 (Western Sydney University) Postdoctoral Research: Cancer Biology Group, University of Sydney (2018–2022) Her research interests include cell cycle regulation, herbal medicine anticancer mechanisms, and diagnostic technology development. Key projects involve detecting protein interactions with chemicals using SERS and identifying intracellular protein locations in cancer cells. Teaching roles include Unit Convenor for Analysis and Measurement and Biomolecules , and involvement in Advanced Analysis and Measurement . Publications span plant-derived compounds (e.g., Agrimol B, Apigenin) targeting cancer cell cycles, SERS-based biosensors, and molecular mechanisms like p27Kip1 signaling. Collaborations emphasize interdisciplinary approaches to cancer biology and translational research. Advising and grants: Currently leading three projects on plant medicine, SERS detection, and cancer cell cycle re-entry. No student advisees listed. Labs/Teams: Collaborations with Prof. Wang’s group (SERS technology) and APAF (proteomics).

Diana S-L. ChowView profile

Professor

• Translational Drug Development
• Oncology
• Pharmacokinetics
• +3 more

Diana S-L. Chow is a Professor in the Department of Pharmacological and Pharmaceutical Sciences at the University of Houston College of Pharmacy . She also holds the Paula & John J. Lovoi Sr. Endowed Professor in Drug Discovery and Development and serves as Director of the Institute of Drug Education and Research . B.S. in Pharmacy, National Taiwan University, School of Pharmacy M.S. in Natural Product Chemistry, Ohio State University Ph.D. in Pharmaceutics, University of British Columbia Dr. Chow's research spans 40 years of translational drug development with a focus on anti-cancer therapies . She has pioneered formulations resulting in FDA-approved products like Busulfex® , with ongoing work on lung, pancreatic, and prostate cancer treatments. Her recent studies expand to underrepresented minority (URM) populations , pediatrics, and neurologically injured patients, emphasizing pharmacokinetics/pharmacodynamics (PK/PD) optimization. Her publications highlight expertise in analytical method development (e.g., LC-MS/MS assays), nanoparticle-based drug delivery , and neuroprotective agents . Key themes include preclinical-to-clinical translation , metabolite quantification , and bioavailability enhancement . 2023 Meritorious Achievement Award, UH College of Pharmacy 2023 Pharmaceutical Sciences Alumni Agent of Change, University of British Columbia 2016 Fellow, National Academy of Inventors 2009 Inventor of the Year, HIPLA Dr. Chow mentors extensively, with recognition as Outstanding Graduate Mentor (2022, 2021), and contributes to graduate education and research infrastructure through her directorship.

• Analytical Chemistry
• Mass Spectrometry
• Biomaterials
• +12 more

Lisa Elviri is an Associate Professor in Analytical Chemistry at the Department of Pharmacy, University of Parma, Faculty of Sciences. She holds a PhD in Chemical Sciences (Analytical Chemistry) from the University of Parma and has been a tenured researcher since 2004. Education: PhD in Chemical Sciences (Analytical Chemistry, University of Parma); Laurea in Chemistry (University of Parma). Her research spans analytical chemistry , mass spectrometry , biomaterials , 3D printing , and clinical diagnostics . She focuses on developing LC-MS and immunoenzymatic methods, validating techniques for pharmaceutical analysis, and designing chitosan-based scaffolds for tissue regeneration. Recent publications highlight work on Alzheimer’s disease (PCSK9 inhibition, APOE4 genotype studies), 3D-printed medical devices , and biorefinery quality monitoring using spectroscopy. Her teaching includes Analytical Chemistry for 5-year Master’s programs in Pharmacy and Pharmaceutical Chemistry. She has authored 75 international publications, 140 conference communications, and holds an H-index of 26 (Google Scholar). Her office is located at the Science and Technology Campus, Parma.

Gungun LinView profile

Senior Lecturer

• Microfluidics
• Lab-on-a-Chip Technologies
• Magneto-MEMS
• +5 more

Dr. Gungun Lin is a Senior Lecturer and Senior Research Fellow at the School of Mathematical and Physical Sciences, University of Technology Sydney (UTS). He is also a core member of the Institute for Biomedical Materials and Devices (IBMD). His academic journey includes a Master of Science from the University of Ulm (Germany) and a PhD (Summa Cum Laude) from Chemnitz University of Technology (Germany). Dr. Lin’s research focuses on microfluidics, lab-on-a-chip technologies, magneto-MEMS, and biomedical applications of smart micro/nanorobots. He has led over $6M in research funding, including ARC DECRA and NHMRC fellowships. Research Interests: Dr. Lin’s work spans fundamental and applied aspects of microfluidics, magnetic microrobots, biosensing, and functional nanomaterials. He investigates magneto-electrical properties of nanostructures for sensing and actuation, and develops high-dimensional bioanalysis tools using advanced materials and microfabrication techniques. Recent projects include in vivo imaging systems, wearable sensors, and tumor organoid models for drug screening. Grants & Awards: He has secured major grants including ARC Discovery Projects (DP250101003), NHMRC Early Career Fellowships, and ARC IDEAL Hub funding. His awards include the 2024 Vice Chancellor's Award for Research Excellence and 2023 Dean’s Award for Science & Collaboration. Teaching & Supervision: Dr. Lin teaches courses like Chemistry & Materials Science and Advanced Nanomaterials. He supervises PhD/Master’s students in microfluidics, microrobotics, and biomedical engineering. Notable supervisees include Zelyu Chen (PhD candidate, 2023–present) and Guocheng Fang (PhD alumnus). Labs & Collaborations: His lab is part of UTS’s ARC High-throughput Device Fabrication Facility. Collaborations span industries and institutions like the Australia-China Joint Research Center for Point-of-Care Testing and the NHMRC.

Manel del ValleView profile

Professor

• Analytical Chemistry
• Electrochemistry
• Sensor Technology
• +6 more

Manel del Valle is a Full Professor of Analytical Chemistry at the Autonomous University of Barcelona (UAB), leading the Sensors & Biosensors Group. He specializes in electrochemical sensors, electronic tongues, and biosensor arrays, with contributions to environmental, pharmaceutical, and security applications. His work integrates nanotechnology and artificial intelligence for advanced data processing. PhD in Chemistry (1992) and B.Sc. in Chemistry (1986) from UAB. Former roles: Associate Professor (1997–2018), Assistant Professor (1989–1997). Research interests focus on sensor array design, electrochemical impedance spectroscopy, and automated analytical systems. He has coordinated EU projects like BORDERSENS (H2020) and authored over 220 publications with an h-index of 84. Awards include the ICREA Academy Distinction and multiple research sexennia. Awards: 3rd National Prize for Studies, Extraordinary Doctorate Award, Medical Journal Research Award. Supervised 28 doctoral theses and 36 final projects across chemistry, engineering, and environmental sciences. Current projects include development of portable drug detection devices and bioelectronic tongues for environmental monitoring. Collaborates widely on electronic tongue applications in food, pharmaceuticals, and security.

Robert C DunnView profile

Professor

• Analytical Chemistry
• Biophysical Chemistry
• Nanotechnology
• +5 more

Robert C. Dunn is a Professor in the Department of Chemistry at the University of Kansas, specializing in analytical and physical chemistry. His research focuses on advanced microscopy techniques, membrane dynamics, and capillary electrophoresis innovations. Dunn holds a B.S. from California State University (1988), M.S. and Ph.D. from University of California, San Diego (1990, 1992), followed by postdoctoral work at Pacific Northwest Laboratory (1993-1995). Key research areas include single molecule spectroscopy, nuclear pore complex dynamics, and development of high-resolution optical methods like near-field scanning optical microscopy (NSOM) and scanning resonator microscopy (SRM). He pioneered high-speed capillary electrophoresis (HSCE) with back-scatter interferometry for rapid, label-free analysis. His lab explores lung surfactant stability and nuclear transport mechanisms, with applications in biomedical diagnostics and gene therapy. Awards include student recognition such as the Takeru Higuchi and John R. Shapley Awards. Dunn mentors graduate and undergraduate students in instrumentation development and biophysical studies. His work integrates advanced optical techniques with biological systems, published in journals like Science Reports , Analytical Chemistry , and ACS Photonics .

ANA DE CASTRO RIOSView profile

Professor

• Toxicology
• Forensic Toxicology
• Analytical Chemistry
• +12 more

Ana de Castro Ríos is a Professor at the University of Santiago de Compostela, affiliated with the Faculty of Pharmacy, the Department of Forensic Sciences, Pathological Anatomy, Gynecology and Obstetrics and Pediatrics, and the Institute of Forensic Sciences "Luis Concheiro" (INCIFOR). She is an active member of the FORTOX (Forensic Toxicology) research group, focusing on advanced analytical methods in toxicology. Her research interests lie primarily in Toxicology , Forensic Toxicology , and Analytical Chemistry , with a strong emphasis on developing and validating LC-MS/MS methods for detecting drugs in alternative biological matrices such as hair, nails, oral fluid, and meconium. Her work bridges clinical and forensic applications, including therapeutic drug monitoring, occupational exposure assessment, drug-impaired driving, and perinatal drug exposure. The recent trend in her publications (2019–2024) demonstrates a consistent focus on the application of liquid chromatography-tandem mass spectrometry for multi-analyte detection in challenging matrices. Her research spans forensic contexts like drug-facilitated crimes and DUID profiling, as well as clinical areas such as immunosuppressant monitoring and neonatal exposure to tobacco and synthetic drugs. PhD in Toxicology, University of Santiago de Compostela, 2007 Ana de Castro Ríos has contributed significantly to the validation and application of analytical methods in forensic and clinical toxicology. Her publications reflect active collaboration and leadership in method development, particularly for detecting drugs in keratinous tissues and meconium. There is no mention of grant funding or student supervision in the provided texts. She is involved in research that supports legal and medical investigations through robust analytical science. She maintains an active research profile with publications up to 2024, indicating ongoing scientific contributions in her field.

Rupali Rajendra BhadaneView profile

Researcher

• Computational Biology
• Drug Design
• Molecular Dynamics Simulations
• +9 more

Rupali Rajendra Bhadane is a postdoctoral researcher at Åbo Akademi University's Pharmaceutical Science Laboratory (PSL) and Structural Bioinformatics Laboratory (SBL), contributing to interdisciplinary science under the Faculty of Natural Sciences and Technology. Her work spans computational biology, drug design, and sustainable material development. PhD in Pharmacy 8 years of undergraduate teaching experience Her research integrates virtual screening , molecular dynamics simulations , and DFT calculations to advance drug discovery (e.g., Glycomimetic SGLT2 inhibitors , HDAC-2 modulators ), while also applying computational methods to analyze bio-based adhesive materials and virus-mimetic nanoparticles . Recent publications highlight her work on Covid-19 spike protein mutations , g-quadruplex targeting , and core/shell nanostructures for siRNA delivery. She actively contributes to datasets through the Finnish National Protein Crystallography Consortium and European Synchrotron Radiation Facility . Current projects include D2V: From Dust to Value (2023-2026), focusing on circular bio-based residues with Business Finland funding. Her work aligns with UN SDGs for health innovation and environmental sustainability.

• Analytical Chemistry
• Pharmaceutical Analysis
• Separation Techniques
• +7 more

Prof. Dr. Hermann Wätzig is a faculty member at the Faculty of Life Sciences of Technische Universität Braunschweig , leading the Research Group of Pharmaceutical Analysis and Quality Control at the Institute of Medicinal and Pharmaceutical Chemistry . His research focuses on analytical chemistry and pharmaceutical quality assurance, with collaborations across academia and industry. Education and Career : Studied pharmacy at Freie Universität Berlin (1981–1985) PhD in HPLC-related research (1989) Lecturer at the Institute of Pharmacy in Würzburg (1990) Habilitation (1995) Appointed Professor of Pharmaceutical Chemistry at TU Braunschweig (1999) Research Interests include: Separation techniques (CE, SDS-PAGE, HPLC, mass spectrometry) Statistical process control for pharmaceutical quality Affinity capillary electrophoresis for protein interactions Optimization of analytical methods in bioanalysis Precision and accuracy in chromatography and gel electrophoresis Leadership and Editorial Roles : Chair of the German Pharmaceutical Society’s pharmaceutical analysis division (since 2001) Editor-in-Chief of Electrophoresis journal Scientific committee member of BfArM, CE Pharm, and ISEAC Associate Director of CASSS Expert for the European Pharmacopoeia Visiting Professor at Shizuoka University